VG
Vikas Gupta
About Vikas Gupta
Data last updated:
Vikas Gupta is a Ceo at Alkem Laboratories Limited (since 2023), Additional Director at Enzene Biosciences Limited (since 2025) and Additional Director at Adroit Biomed Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Life Sciences and FMCG. The 3 current companies with reported revenue have a combined latest revenue of ₹15,735 Cr; the largest is Alkem Laboratories Limited at ₹15,296 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 22 Sep 2023 | 1973 | ₹15,296 Cr (FY 2026) | Active | |
| Additional Director | 14 Aug 2025 | 2006 | ₹385 Cr (FY 2025) | Active | |
| Additional Director | 17 Apr 2025 | 2009 | ₹53.89 Cr (FY 2024) | Active | |
| Director | 12 Jul 2024 | 2024 | Active |
Board colleagues of Vikas Gupta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikas Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikas Gupta
Vikas Gupta currently holds 4 directorships: Alkem Laboratories Limited (Ceo, since 22 Sep 2023, revenue ₹15,296 Cr (FY 2026)); Enzene Biosciences Limited (Additional Director, since 14 Aug 2025, revenue ₹385 Cr (FY 2025)); Adroit Biomed Limited (Additional Director, since 17 Apr 2025, revenue ₹53.89 Cr (FY 2024)); Alixer Nexgen Therapeutics Limited (Director, since 12 Jul 2024).
Vikas Gupta was first appointed on 22 Sep 2023 as Ceo at Alkem Laboratories Limited. The most recent appointment on record is 14 Aug 2025 at Enzene Biosciences Limited.
The 3 current companies of Vikas Gupta that report revenue have a combined latest revenue of ₹15,735 Cr: Alkem Laboratories Limited ₹15,296 Cr (FY 2026); Enzene Biosciences Limited ₹385 Cr (FY 2025); Adroit Biomed Limited ₹53.89 Cr (FY 2024).
The current boards of Vikas Gupta's companies include Basudeo Narayan Singh (Alkem Laboratories Limited), Diwakar Gupta (Alkem Laboratories Limited), Laxmana Ranjal Shenoy (Alkem Laboratories Limited), Madhurima Singh (Alkem Laboratories Limited), Manish Narang (Alkem Laboratories Limited), Mritunjay Kumar Singh (Alkem Laboratories Limited), among others.